Navigation Links
Caution Urged in Intensive Treatment of Type 2 Diabetes
Date:7/27/2011

WEDNESDAY, July 27 (HealthDay News) -- Intensive glucose-lowering treatment for people with type 2 diabetes doesn't reduce the risk of cardiovascular-related death and doctors need to be cautious about prescribing this type of treatment, a new study suggests.

Patients with type 2 diabetes are at increased risk for cardiovascular disease. Intensive glucose-lowering treatment is widely used for these patients even though previous research hasn't shown any clear benefits, the researchers pointed out in a report published in the July 27 online edition of the BMJ.

In the new study, Catherine Cornu, a research physician at the Clinical Investigation Centre, Louis Pradel Hospital in Bron, France, and colleagues reviewed 13 studies that included a total of 34,533 diabetes patients -- 18,315 who underwent intensive glucose-lowering treatment and 16,218 who received standard treatment.

Intensive treatment did not significantly reduce cardiovascular death or all-cause death, but it was associated with a 15 percent reduced risk of non-fatal heart attacks and a 10 percent reduced risk of microalbuminuria, an indicator of kidney problems and heart disease, the researchers found.

But, intensive treatment was also linked with a more than twofold increase in the risk of dangerously low blood glucose levels (severe hypoglycemia), the investigators noted in a journal news release.

Over a five-year treatment period, 117 to 150 patients would need to undergo intensive glucose-lowering treatment to prevent one heart attack, 32 to 142 patients would have to be treated to prevent one case of microalbuminuria, and 15 to 52 would need to be treated to avoid one severe hypoglycemic event, the researchers calculated.

"Intensive glucose-lowering treatment of type 2 diabetes should be considered with caution and therapeutic escalation should be limited," the authors concluded.

More information

The U.S. National Institute of Diabetes and Digestive and Kidney Diseases has more about type 2 diabetes.

-- Robert Preidt

SOURCE: BMJ, news release, July 26, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. People with prediabetes not taking adequate precautions to avoid diabetes
2. ATV and motocross sports - high velocity toys merit caution
3. New York Medical Malpractice Attorney Recommends Cancer Patients Take Precautionary Steps Before Undergoing Radiation Therapy
4. Study cautions: Psychotropic medications overprescribed to children
5. As FDA Eyes Prostate Cancer Drugs, Experts Urge Caution
6. As Autism Web Sites Boom, Experts Urge Caution
7. SNM cautions that Canadas Chalk River coming back online will not solve long-term isotope shortage
8. New guideline from ASH and ASCO recommends caution regarding ESA use in cancer patients
9. Use Anemia Drugs for Cancer Patients With Caution, Experts Say
10. Docs Claim Transplant Cured Man of HIV, But Experts Urge Caution
11. Take Safety Precautions in the Snow, Ice
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Caution Urged in Intensive Treatment of Type 2 Diabetes 
(Date:4/25/2017)... ... ... Saad B. Chaudhary, MD is committed to providing the highest quality of spine care to ... preventative care with all my patients to alleviate possible future issues. I am pleased to ... my office and my trained staff will assist you in any way possible.” , Dr. ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol ... is introducing Flexadin UCII, part of the EQUISTRO line, at this week’s Rolex ... in horses at the immunologic level. , The scientifically-developed Flexadin UCII supports the ...
(Date:4/24/2017)... ... ... Michael Vick announced his retirement earlier this year from the NFL after thirteen ... in the 2001 NFL Draft, to the Atlanta Falcons, made four Pro Bowl appearances ... yards by a quarterback (6,109) and the most rushing yards by a quarterback in ...
(Date:4/24/2017)... ... April 24, 2017 , ... NEPC Director Kevin Welner has ... Research Award. The award honors scholars exemplary in their capacity to communicate important ... has demonstrated the capacity to deepen the public’s understanding and appreciation of the ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... Sean Fay ... Oxiclean, Space Bag, Sonicare Toothbrush, Juiceman Juicer, and the George Foreman Grill (which sold ... any other marketer in the last 25 years. , Now, due to changes in ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... -- New research provides evidence that an old drug may provide ... released today that will be presented at the American ... Boston , April 22 to 28, 2017. ... the oral drug levodopa has long been considered the gold ... disease progresses, the effects of the medication can partially wear ...
(Date:4/19/2017)... April 19, 2017  SARES•REGIS Group leased the ... developing at Conejo Spectrum Business Park in ... Atara Biotherapeutics, Inc. , a biopharmaceutical company developing ... diseases that have been underserved by scientific innovation, ... for cancer, autoimmune and infectious disease. ...
(Date:4/18/2017)... -- Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical ... Gynecology markets with innovative and proprietary products, will release ... 2017 after the market close on Tuesday, May 2, ... conference call and webcast to discuss its financial results ... 4:30 p.m. Eastern Time (3:30 p.m. Central Time). ...
Breaking Medicine Technology: